Literature DB >> 15477631

Homocysteine and cognitive function in elderly people.

Angeles Garcia1, Katherine Zanibbi.   

Abstract

Dementia is highly prevalent among elderly people, and projections show that the number of people affected might triple over the next 50 years, mainly because of a large increase in the oldest-old segment of the population. Because of this and the disease's devastating effects, measures for the prevention and early detection of dementia are crucial. Age and years of education are among the most relevant risk factors for dementia, but in recent years the role of homocysteine has also been investigated. Homocysteine is an amino acid produced in the metabolism of methionine, a process dependent on the B vitamins cobalamin, vitamin B6 and folic acid. There is evidence that increased serum homocysteine levels are associated with declining cognitive function and dementia. We review this evidence in addition to the potential mechanisms through which homocysteine acts on the brain to cause cognitive dysfunction, the metabolism of homocysteine and factors associated with alteration of the normal metabolism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477631      PMCID: PMC522658          DOI: 10.1503/cmaj.1031586

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  71 in total

1.  Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals.

Authors:  P S Sachdev; M Valenzuela; X L Wang; J C L Looi; H Brodaty
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

2.  Homocysteine, vitamin B6, and vascular disease in AD patients.

Authors:  J W Miller; R Green; D M Mungas; B R Reed; W J Jagust
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

3.  Functional vitamin B(12) deficiency and Alzheimer disease.

Authors:  A McCaddon; B Regland; P Hudson; G Davies
Journal:  Neurology       Date:  2002-05-14       Impact factor: 9.910

4.  Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages.

Authors:  Janet Bryan; Eva Calvaresi; Donna Hughes
Journal:  J Nutr       Date:  2002-06       Impact factor: 4.798

5.  Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease.

Authors:  Eva Hogervorst; Helen Mendes Ribeiro; Andrew Molyneux; Marc Budge; A David Smith
Journal:  Arch Neurol       Date:  2002-05

6.  Homocysteine, B vitamin status, and cognitive function in the elderly.

Authors:  Susan J Duthie; Lawrence J Whalley; Andrew R Collins; Steve Leaper; Kerstin Berger; Ian J Deary
Journal:  Am J Clin Nutr       Date:  2002-05       Impact factor: 7.045

7.  Is low-dose oral cobalamin enough to normalize cobalamin function in older people?

Authors:  Angela Garcia; Alicia Paris-Pombo; Lisa Evans; Andrew Day; Morris Freedman
Journal:  J Am Geriatr Soc       Date:  2002-08       Impact factor: 5.562

8.  Plasma homocysteine and cognitive impairment in an older British African-Caribbean population.

Authors:  Robert Stewart; Belinda Asonganyi; Roy Sherwood
Journal:  J Am Geriatr Soc       Date:  2002-07       Impact factor: 5.562

9.  Association of plasma homocysteine concentration with atherosclerotic carotid plaques and lacunar infarction.

Authors:  Tsutomu Sasaki; Manabu Watanabe; Yoji Nagai; Taku Hoshi; Masashi Takasawa; Masaru Nukata; Akihiko Taguchi; Kazuo Kitagawa; Naokazu Kinoshita; Masayasu Matsumoto
Journal:  Stroke       Date:  2002-06       Impact factor: 7.914

10.  Homocysteine, MTHFR 677C-->T polymorphism, and risk of ischemic stroke: results of a meta-analysis.

Authors:  P J Kelly; J Rosand; J P Kistler; V E Shih; S Silveira; A Plomaritoglou; K L Furie
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

View more
  19 in total

1.  Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification.

Authors:  Martha Savaria Morris; Paul F Jacques; Irwin H Rosenberg; Jacob Selhub
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

2.  Insulin, glucose and glycated hemoglobin in Alzheimer's and vascular dementia with and without superimposed Type II diabetes mellitus condition.

Authors:  R O Domínguez; E R Marschoff; E M Guareschi; M G Repetto; A L Famulari; M A Pagano; J A Serra
Journal:  J Neural Transm (Vienna)       Date:  2007-08-30       Impact factor: 3.575

3.  Folic acid attenuates cognitive dysfunction in streptozotocin-induced diabetic rats.

Authors:  Rui Yang; Rong-Ping Chen; Hong Chen; Hua Zhang; De-Hong Cai
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 4.  Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.

Authors:  Sophie Gillette-Guyonnet; Marion Secher; Bruno Vellas
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

5.  Total serum homocysteine levels do not identify cognitive dysfunction in multimorbid elderly patients.

Authors:  S Hengstermann; G Laemmler; A Hanemann; A Schweter; E Steinhagen-Thiessen; A Lun; R-J Schulz
Journal:  J Nutr Health Aging       Date:  2009-02       Impact factor: 4.075

6.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

7.  Effect of lipopenic and hypotensive treatment on homocysteine levels in type 2 diabetics.

Authors:  Mabrouka El Oudi; Zied Aouni; Haroun Ouertani; Chakib Mazigh; Salem Machghoul
Journal:  Vasc Health Risk Manag       Date:  2010-05-25

Review 8.  The role of B vitamins in preventing and treating cognitive impairment and decline.

Authors:  Martha Savaria Morris
Journal:  Adv Nutr       Date:  2012-11-01       Impact factor: 8.701

9.  [Does an association between increased homocystein levels and cognitive dysfunction also exist in multimorbid geriatric patients].

Authors:  S Hengstermann; A Hanemann; R Nieczaj; N Abdollahnia; A Schweter; E Steinhagen-Thiessen; A Lun; G Lämmler; R-J Schulz
Journal:  Z Gerontol Geriatr       Date:  2008-06-13       Impact factor: 1.281

10.  Total serum homocysteine levels do not identify cognitive dysfunction in multimorbid elderly patients.

Authors:  S Hengstermann; G Laemmler; A Hanemann; A Schweter; E Steinhagen-Thiessen; A Lun; R-J Schulz
Journal:  J Nutr Health Aging       Date:  2008 Jun-Jul       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.